Eton Pharmaceuticals Community

Key Takeaways Strategic acquisitions and product launches are expected to drive significant revenue growth and expand market reach in pediatrics and rare diseases. Focusing on domestic markets through targeted out-licensing enhances profitability by reducing global operational expenses.